Biomarker identification and validation
Biomarker identification and validation
PsyRING's experience with biomarkers can bridge the preclinical-clinical gap and allow the rapid assessment of clinical efficacy.
World-leading expertise, combined with access to state-of-the-art genomic, proteomic and bioinformatic facilities, provides a unique integrated service, to identify and validate potential biomarkers.
- Access to clinical tissue
- State-of-the-art facility
- Expertise in analysis
Potential biomarkers can be assessed in relevant clinical populations through Psyring's excellent collaborative links with the NHS.